Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CDK12-IN-5 is a pyrazolotriazine compound that effectively inhibits CDK12, with an IC50 value of 23.9 nM at a high ATP concentration of 2 mM. However, CDK12-IN-5 does not exhibit inhibitory effects on CDK2/Cyclin E (IC50 = 173 μM) and CDK9/Cyclin T1 (IC50 = 127 μM) at the same high ATP concentration of 2 mM, as stated in WO2021116178A1.
Description | CDK12-IN-5 is a pyrazolotriazine compound that effectively inhibits CDK12, with an IC50 value of 23.9 nM at a high ATP concentration of 2 mM. However, CDK12-IN-5 does not exhibit inhibitory effects on CDK2/Cyclin E (IC50 = 173 μM) and CDK9/Cyclin T1 (IC50 = 127 μM) at the same high ATP concentration of 2 mM, as stated in WO2021116178A1. |
Targets&IC50 | CDK12:23.9 nM (IC50), CDK2-CyclinE:173 μM (IC50), CDK9-CyclinT1:127 μM (IC50) |
In vitro | CDK12-IN-5 (Example 426) selectively suppresses BRCA1 mRNA levels in MDA-MB-231 cells (IC50 = 3.23 nM) without affecting CAL-120 cells[1]. It exhibits antiproliferative effects on both MDA-MB-231 (IC50 = 4.19 nM) and CAL-120 cells (IC50 = 3.57 nM)[1]. Additionally, CDK12-IN-5 demonstrates a high selectivity for CDK12 inhibition with an IC50 to degradation (DC50) CDK12 ratio of 32[1]. |
Synonyms | CDK12-IN-5 |
Molecular Weight | 454.365 |
Formula | C18H15F5N8O |
CAS No. | 2651200-35-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CDK12-IN-5 2651200-35-8 CDK-12-IN-5 CDK12IN5 CDK12 IN 5 inhibitor inhibit